Huntington National Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.4K Buy
119
+17
+17% +$5.79K ﹤0.01% 1426
2025
Q4
$40.6K Buy
102
+1
+1% +$443 ﹤0.01% 1332
2025
Q3
$46.1K Sell
101
-94
-48% -$38.3K ﹤0.01% 1296
2025
Q2
$63.6K Sell
195
-3
-2% -$830 ﹤0.01% 1153
2025
Q1
$53.5K Buy
198
+125
+171% +$32.1K ﹤0.01% 1153
2024
Q4
$17.2K Sell
73
-21
-22% -$5.52K ﹤0.01% 1588
2024
Q3
$25.9K Buy
94
+45
+92% +$11.7K ﹤0.01% 1430
2024
Q2
$11.9K Sell
49
-18
-27% -$2.84K ﹤0.01% 1630
2024
Q1
$10K Buy
67
+35
+109% +$5.84K ﹤0.01% 1679
2023
Q4
$6.13K Buy
32
+2
+7% +$341 ﹤0.01% 1823
2023
Q3
$5.31K Sell
30
-12
-29% -$2.29K ﹤0.01% 1790
2023
Q2
$7.98K Buy
42
+23
+121% +$4.56K ﹤0.01% 1644
2023
Q1
$3.81K Buy
19
+18
+1,800% +$3.78K ﹤0.01% 1804
2022
Q4
$238 Buy
+1
New +$213 ﹤0.01% 1986
2022
Q1
Sell
-81
Closed -$14K 2027
2021
Q4
$14K Sell
81
-5
-6% -$929 ﹤0.01% 1480
2021
Q3
$16K Buy
86
+5
+6% +$938 ﹤0.01% 1313
2021
Q2
$14K Hold
81
﹤0.01% 1358
2021
Q1
$11K Buy
+81
New +$12.2K ﹤0.01% 1306
2020
Q2
Sell
-296
Closed -$32K 1490
2020
Q1
$32K Hold
296
﹤0.01% 920
2019
Q4
$34K Buy
+296
New +$29.5K ﹤0.01% 1062
2019
Q1
Sell
-1,000
Closed -$73K 1539
2018
Q4
$73K Buy
+1,000
New +$76.9K ﹤0.01% 738
2013
Q4
Sell
-2,750
Closed -$176K 1709
2013
Q3
$176K Sell
2,750
-250
-8% -$12.5K 0.01% 712
2013
Q2
$93K Buy
+3,000
New +$79.8K ﹤0.01% 873

Other funds holding ALNY